Movano Health Applies Advanced AI through Deep Learning To Deliver Improved Accuracy Of Heart Rate In Motion

6/13/24 9:17:27 AM ET

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Health Care

Get the next $MOVE alert in real time by email

Movano Health (Nasdaq: MOVE) announced major advances in the accuracy of its heart rate in motion algorithm following the implementation of deep learning into the processing. The Company recently released an engineering accuracy study directed by Movano Health Founder and CTO Michael Leabman, Enhanced Heart Rate in Motion Accuracy with the Evie Ring Using Advanced Deep Learning Algorithms, which demonstrates the value of deep learning integration into heart rate (HR) algorithms for improved accuracy.

Get the next $MOVE alert in real time by email

Chat with this insight

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$MOVE

Date	Price Target	Rating	Analyst

More analyst ratings

Movano Health Reports Q3 2024 Financial Results and Provides Business Update
Highlights successful Evie Ring back-in-stock execution Updates status of EvieMED 510(k) application review Focuses on launch of EvieMED and securing B2B opportunities Conference Call at 2:00 PM PT/ 5:00 PM ET Today PLEASANTON, Calif., Nov. 14, 2024 /PRNewswire/ -- Movano Health (NASDAQ:MOVE), a pioneer in health technology, reported third quarter 2024 results and provided a business update. The Company continues to remain focused on three key business initiatives. Successful execution of the Evie Ring direct-to-consumer business (D2C) following the September 17th back-in-sto
11/14/24 4:05:00 PM ET
$MOVE
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Health Care
Movano Health Reports Q2 2024 Financial Results and Provides Business Update
Prepares for September 17, 2024, Evie Ring back in stock dateAnnounces brand partnership with digital creator Heidi D'AmelioFocuses on launch of EvieMED and securing B2B opportunitiesConference Call at 2:00 PM PT/ 5:00 PM ET Today PLEASANTON, Calif., Aug. 14, 2024 /PRNewswire/ -- Movano Health (NASDAQ:MOVE), a pioneer in health technology, reported second quarter 2024 results and provided a business update. Following the successful close of the Company's April 2024 $24.1 million private placement that included a seed investment from a tier 1 multi-billion dollar medical device
8/14/24 4:05:00 PM ET
$MOVE
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Health Care
Movano Health Provides Progress Update on EvieMED Regulatory Filing
Company continues to work with FDA to bring this pioneering healthcare product to market PLEASANTON, Calif., Aug. 5, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) plans to meet with the FDA in mid-August, as part of the Company's ongoing process to secure a 510(k) clearance for the EvieMED Ring, a wearable designed to not only provide medical device functionality through its pulse oximetry feature, but also offer numerous wellness metrics related to sleep, activity and mood/energy/symptom logging. On April 21, 2024, Movano Health filed an updated 510(k) for the EvieMED Ring's pulse oximetry feature. At the time of the filing and based on prior interactions with the agency and its protoco
8/5/24 9:00:00 AM ET
$MOVE
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Health Care

$MOVE
Press Releases

Fastest customizable press release news feed in the world

Movano Health Reports Q3 2024 Financial Results and Provides Business Update
Highlights successful Evie Ring back-in-stock execution Updates status of EvieMED 510(k) application review Focuses on launch of EvieMED and securing B2B opportunities Conference Call at 2:00 PM PT/ 5:00 PM ET Today PLEASANTON, Calif., Nov. 14, 2024 /PRNewswire/ -- Movano Health (NASDAQ:MOVE), a pioneer in health technology, reported third quarter 2024 results and provided a business update. The Company continues to remain focused on three key business initiatives. Successful execution of the Evie Ring direct-to-consumer business (D2C) following the September 17th back-in-sto
11/14/24 4:05:00 PM ET
$MOVE
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Health Care
Movano Health Announces Completion of Clinical Study with Cuffless RF Blood Pressure Device
New hardware boasts significant improvements to reduce noise and generate higher fidelity signals PLEASANTON, Calif., Nov. 7, 2024 /PRNewswire/ -- Movano Health Inc. (NASDAQ:MOVE) announced today that it has tested its newly developed blood pressure wrist wearable as part of its November 5th and 6th hypoxia clinical trial that took place at the University of California, San Francisco. The updated device features an additional 12 mmWave antennas which together with Movano Health's custom IC delivers enhanced data collection with less impact of placement while also featuring a slimmer design, making it easier and more comfortable to wear. In addition, the new wearable monitors a host of other
11/7/24 8:00:00 AM ET
$MOVE
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Health Care
Movano Health Provides Update on Investigation to Expose Apparent Stock Manipulation Following Reverse Stock Split
Company Continues to Work with Securities Regulators, Legal Advisors and Other Partners to Protect Interests of Shareholders PLEASANTON, Calif., Nov. 4, 2024 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) (the "Company") provided an update on an investigation to expose apparent manipulation in trading of the Company's common shares, following the recent announcement of a shareholder approved reverse stock split. Based on its preliminary investigation, the Company believes that between the announcement of the reverse split on October 25, 2024, and its effective date on October 2
11/4/24 8:00:00 AM ET
$MOVE
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Health Care

Movano Health Applies Advanced AI through Deep Learning To Deliver Improved Accuracy Of Heart Rate In Motion

Chat with this insight

Recent Analyst Ratings for
$MOVE

$MOVE
SEC Filings

SEC Form 10-Q filed by Movano Inc.

Movano Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

Movano Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits

$MOVE
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

SEC Form 4 filed by Director Caballero Ruben

SEC Form 4 filed by Director Fairbairn Emily

SEC Form 4 filed by Director Cullinan Brian

$MOVE
Large Ownership Changes

This live feed shows all institutional transactions in real time.

SEC Form SC 13G filed by Movano Inc.

SEC Form SC 13G/A filed by Movano Inc. (Amendment)

SEC Form SC 13G filed by Movano Inc.

$MOVE
Market Insights

Live Market Insights

Shares of companies within the broader technology sector are trading higher amid overall market strength as investors assess this week's inflation data.

12 Information Technology Stocks Moving In Friday's Pre-Market Session